新型冠状病毒在慢性阻塞性肺疾病患者肺组织中的分子相互作用 - Suppr

Suppr

超能文献

Molecular Interactions of SARS-CoV-2 in Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease.

作者信息

Agusti Alvar, Sibila Oriol, Casas-Recasens Sandra, Mendoza Nuria, Perea Lidia, Lopez-Giraldo Alejandra, Faner Rosa

机构信息

Centro de Investigación Biomédica en Red de Enfermedades Respiratorias Madrid, Spain.

Institut d'Investigacions Biomediques August Pi i Sunyer Barcelona, Spain.

出版信息

Ann Am Thorac Soc. 2021 Nov;18(11):1922-1924. doi: 10.1513/AnnalsATS.202006-619RL.

DOI:10.1513/AnnalsATS.202006-619RL

PMID:33950792

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8641835/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6df/8641835/6446124600e4/AnnalsATS.202006-619RLf1.jpg

相似文献

Molecular Interactions of SARS-CoV-2 in Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease.新型冠状病毒在慢性阻塞性肺疾病患者肺组织中的分子相互作用

Ann Am Thorac Soc. 2021 Nov;18(11):1922-1924. doi: 10.1513/AnnalsATS.202006-619RL.

Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.ACE2 水平失衡 - COPD 患者发生严重 COVID-19 结局的一个可能原因。

J Pathol Clin Res. 2021 Sep;7(5):446-458. doi: 10.1002/cjp2.224. Epub 2021 May 12.

Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.生物信息学和系统生物学方法鉴定 SARS-CoV-2 感染对特发性肺纤维化和慢性阻塞性肺疾病患者的影响。

Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab115.

Lung Spatial Profiling Reveals a T Cell Signature in COPD Patients with Fatal SARS-CoV-2 Infection.肺空间分析揭示 COVID-19 致死患者 COPD 患者中的 T 细胞特征。

Cells. 2022 Jun 7;11(12):1864. doi: 10.3390/cells11121864.

Angiotensin-converting enzyme 2 in peripheral lung club cells modulates the susceptibility to SARS-CoV-2 in chronic obstructive pulmonary disease.外周肺 club 细胞中的血管紧张素转换酶 2 调节慢性阻塞性肺疾病对 SARS-CoV-2 的易感性。

Am J Physiol Lung Cell Mol Physiol. 2022 May 1;322(5):L712-L721. doi: 10.1152/ajplung.00305.2021. Epub 2022 Mar 23.

Diseased lungs may hinder COVID-19 development: A possible reason for the low prevalence of COPD in COVID-19 patients.患病肺部可能阻碍 COVID-19 发展：COVID-19 患者中 COPD 患病率较低的一个可能原因。

Med Hypotheses. 2021 Aug;153:110628. doi: 10.1016/j.mehy.2021.110628. Epub 2021 Jun 9.

Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.吸烟人群和 COPD 患者小气道中内吞作用机制和 ACE2 的失调会增加其对 SARS-CoV-2（COVID-19）感染的易感性。

Am J Physiol Lung Cell Mol Physiol. 2021 Jan 1;320(1):L158-L163. doi: 10.1152/ajplung.00437.2020. Epub 2020 Nov 11.

[The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2].[欧亚治疗师协会关于感染新冠病毒的合并症患者管理策略的专家共识立场]

Ter Arkh. 2020 Oct 14;92(9):108-124. doi: 10.26442/00403660.2020.09.000703.

What Are the Long-term Pulmonary Sequelae of COVID-19 Infection?新型冠状病毒肺炎感染的长期肺部后遗症有哪些？

Radiology. 2022 Jul;304(1):193-194. doi: 10.1148/radiol.220449. Epub 2022 Mar 15.

Automatic algorithm for quantifying lung involvement in patients with chronic obstructive pulmonary disease, infection with SARS-CoV-2, paracoccidioidomycosis and no lung disease patients.用于定量评估慢性阻塞性肺疾病、感染 SARS-CoV-2、副球孢子菌病和无肺部疾病患者肺部受累情况的自动算法。

PLoS One. 2021 Jun 10;16(6):e0251783. doi: 10.1371/journal.pone.0251783. eCollection 2021.

引用本文的文献

Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease.COVID-19 患者中有和没有慢性阻塞性肺疾病患者住院风险的比较。

Respir Med. 2023 Jan;206:107064. doi: 10.1016/j.rmed.2022.107064. Epub 2022 Nov 26.

Inhaled corticosteroids for the treatment of COVID-19.吸入性皮质类固醇治疗 COVID-19。

Eur Respir Rev. 2022 Nov 29;31(166). doi: 10.1183/16000617.0099-2022. Print 2022 Dec 31.

本文引用的文献

COPD & COVID-19.慢性阻塞性肺疾病与2019冠状病毒病

Arch Bronconeumol (Engl Ed). 2021 Mar;57(3):162-164. doi: 10.1016/j.arbr.2021.01.004. Epub 2021 Mar 10.

Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2.感染新型冠状病毒肺炎住院的慢性阻塞性肺疾病患者的临床特征及预后

Int J Chron Obstruct Pulmon Dis. 2021 Jan 5;15:3433-3445. doi: 10.2147/COPD.S276692. eCollection 2020.

ACE inhibition and cardiometabolic risk factors, lung and gene expression, and plasma ACE2 levels: a Mendelian randomization study.血管紧张素转换酶抑制与心脏代谢危险因素、肺和基因表达以及血浆血管紧张素转换酶2水平：一项孟德尔随机化研究

R Soc Open Sci. 2020 Nov 18;7(11):200958. doi: 10.1098/rsos.200958. eCollection 2020 Nov.

Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study.吸入性糖皮质激素与新冠病毒疾病风险及死亡率：一项全国性队列研究

J Clin Med. 2020 Oct 23;9(11):3406. doi: 10.3390/jcm9113406.

Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis.吸烟者、慢性阻塞性肺疾病（COPD）患者和特发性肺纤维化（IPF）患者的人肺组织中参与细胞衰老、端粒和线粒体途径的基因的年龄依赖性评估：与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）、2019冠状病毒病（COVID-19）血管紧张素转换酶2（ACE2）-跨膜丝氨酸蛋白酶2（TMPRSS2）-弗林蛋白酶（Furin）-二肽基肽酶4（DPP4）轴的关联

Front Pharmacol. 2020 Sep 9;11:584637. doi: 10.3389/fphar.2020.584637. eCollection 2020.

Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.吸烟者和 COPD 患者肺泡和支气管上皮中 ACE2 表达增加，ACE2 是 SARS-CoV-2 的进入受体。

Eur Respir J. 2020 Aug 20;56(2). doi: 10.1183/13993003.02378-2020. Print 2020 Aug.

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.在健康人群以及哮喘、COPD、肥胖、高血压和 COVID-19 危险因素患者的组织和免疫细胞中，ACE2、CD147、CD26 和其他 SARS-CoV-2 相关分子的分布。

Allergy. 2020 Nov;75(11):2829-2845. doi: 10.1111/all.14429. Epub 2020 Aug 24.

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。

Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.

Am J Respir Crit Care Med. 2020 Jul 1;202(1):83-90. doi: 10.1164/rccm.202003-0821OC.

Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2.吸烟会增加严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的受体血管紧张素转换酶2（ACE2）在肺部的基因表达。

Am J Respir Crit Care Med. 2020 Jun 15;201(12):1557-1559. doi: 10.1164/rccm.202003-0693LE.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验